Published in Virology on October 01, 1992
Review: The neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol (2011) 1.45
Simian varicella virus induces apoptosis in monkey kidney cells by the intrinsic pathway and involves downregulation of bcl-2 expression. J Virol (2009) 0.91
Simian varicella virus: molecular virology. Curr Top Microbiol Immunol (2010) 0.88
A simian varicella virus (SVV) homolog to varicella-zoster virus gene 21 is expressed in monkey ganglia latently infected with SVV. J Virol (1996) 0.85
Array analysis of simian varicella virus gene transcription in productively infected cells in tissue culture. J Virol (2005) 0.85
Animal models of varicella zoster virus infection. Pathogens (2013) 0.78
Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med (2000) 6.43
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther (2000) 4.33
Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology (1996) 4.02
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med (1995) 3.37
Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry (2001) 3.00
Zoster sine herpete, a clinical variant. Ann Neurol (1994) 2.84
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology (2007) 2.76
Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med (1990) 2.75
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71
Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology (2011) 2.71
Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
Sites of termination of in vitro DNA synthesis on ultraviolet- and N-acetylaminofluorene-treated phi X174 templates by prokaryotic and eukaryotic DNA polymerases. Proc Natl Acad Sci U S A (1981) 2.66
Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A (1981) 2.45
Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol (1996) 2.41
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Varicella-zoster virus DNA in human sensory ganglia. Nature (1984) 2.34
Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med (2001) 2.18
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc Natl Acad Sci U S A (2001) 1.99
Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF. Neurology (2011) 1.85
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Hum Gene Ther (1999) 1.84
Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology (2000) 1.84
Search for varicella zoster virus in giant cell arteritis. Ann Neurol (1998) 1.78
Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes (2001) 1.75
The DNA sequence of the simian varicella virus genome. Virology (2001) 1.67
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66
Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J Virol (1995) 1.66
The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol (2001) 1.65
Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol (1992) 1.65
Varicella-zoster virus reactivation without rash. J Infect Dis (1992) 1.64
In vitro bypass of UV-induced lesions by Escherichia coli DNA polymerase I: specificity of nucleotide incorporation. Proc Natl Acad Sci U S A (1983) 1.64
Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology (1984) 1.64
Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol (1998) 1.59
Extraction of cell-associated varicella-zoster virus DNA with triton X-100-NaCl. J Virol Methods (1982) 1.58
Varicella-zoster virus myelitis: an expanding spectrum. Neurology (1994) 1.53
Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia. J Infect Dis (1992) 1.52
Varicella-zoster virus infection of human mononuclear cells. Virus Res (1987) 1.46
Review: The neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol (2011) 1.45
Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus. Hum Gene Ther (1999) 1.43
Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. J Virol (1993) 1.41
VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41
Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res (1994) 1.41
Effect of acetylated and deacetylated 2-aminofluorene adducts on in vitro DNA synthesis. Proc Natl Acad Sci U S A (1982) 1.40
Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol (1984) 1.38
The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol (1995) 1.36
Isolation of Herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet (1977) 1.30
Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain. J Neuroimmunol (1999) 1.28
A role for DNA polymerase in the specificity of nucleotide incorporation opposite N-acetyl-2-aminofluorene adducts. J Mol Biol (1984) 1.27
Termination of vitro DNA synthesis at AAF adducts in the DNA. Nucleic Acids Res (1980) 1.27
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. J Virol (1999) 1.26
Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J Virol (1999) 1.25
Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol (1996) 1.25
Monoclonal antibody to immediate early protein encoded by varicella-zoster virus gene 62. Virus Res (1990) 1.25
Nucleotide sequence of the mitochondrial genome of Paramecium. Nucleic Acids Res (1990) 1.25
Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1. Cancer Res (1995) 1.22
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol (1973) 1.21
Preherpetic neuralgia. Neurology (1991) 1.20
Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A (2001) 1.19
Zoster myelitis: improvement with antiviral therapy in two cases. Neurology (1996) 1.19
Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol (1995) 1.18
Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies. Lab Invest (1977) 1.18
Mitochondrial DNA and nuclear DNA from normal rat liver have a common sequence. Proc Natl Acad Sci U S A (1983) 1.16
Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler (2004) 1.15
The patterns of varicella zoster virus encephalitis. Hum Pathol (1996) 1.15
Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia. Proc Natl Acad Sci U S A (1988) 1.14
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. J Immunol (1998) 1.13
Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207. Hum Gene Ther (1999) 1.13
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma. Neoplasia (1999) 1.13
Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain. Gene Ther (2005) 1.13
Configuration of latent varicella-zoster virus DNA. J Virol (1995) 1.12